Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Stable Peritoneal dialysis~* Stable Hemodialysis~* Age 18-85 years~Exclusion Criteria:~* use of hypnotics, MAO inhibitors or neuroleptics~* Liver disease~* Participation in drug investigation \< 1 months to start~* Former use of melatonin~* Severe neurological/psychiatric disease~* Allergic to melatonin or additives

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).